D.E. Shaw & Co
SMTI icon

D.E. Shaw & Co’s Sanara MedTech SMTI Stock Holding History

D.E. Shaw & Co’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$280K Buy
16,323
+2,020
+14% +$41.6K ﹤0.01% 4104
2025
Q4 		$334K Buy
+14,303
New +$369K ﹤0.01% 4101

Other funds holding SMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

D.E. Shaw & Co's SMTI Position: Q1 2026 in Review

D.E. Shaw & Co increased its Sanara MedTech (SMTI) stake by 14% in Q1 2026, buying an estimated $41.6K and bringing the position to 16,323 shares worth $280K. The position accounts for ﹤0.01% of the portfolio, ranked #4104.

D.E. Shaw & Co first reported a position in SMTI in Q4 2025 and has held it in 2 quarters since. The position peaked at $334K in Q4 2025. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

  • D.E. Shaw & Co held 16,323 shares of Sanara MedTech worth $280K as of Q1 2026.
  • D.E. Shaw & Co bought 2,020 Sanara MedTech shares in Q1 2026, an estimated $41.6K.
  • Sanara MedTech made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #4104 holding.
  • D.E. Shaw & Co first reported a position in Sanara MedTech in Q4 2025 and has held it in 2 quarters since.
  • D.E. Shaw & Co's Sanara MedTech position peaked at $334K in Q4 2025.
  • 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.